Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perinatal cerebral asphyxia: pharmacological intervention.

A J Gunn1, C E Williams, L Bennet

  • 1Department of Paediatrics, University of Auckland, New Zealand.

Fetal Therapy
|January 1, 1988
PubMed
Summary

Flunarizine, a calcium antagonist, shows neuroprotective effects against perinatal asphyxia, reducing risks of cerebral palsy. MK-801, an amino acid antagonist, effectively prevented seizures following ischemic insults in preclinical models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age at first breeding in Holstein dairy cattle: Effects on age at first calving, production, dystocia, health, and reproduction in primiparous heifers.

Journal of dairy science·2026
Same author

Meta-analysis of the effects of age at first calving on production outcomes, calving difficulty, and reproduction in dairy heifers.

Journal of dairy science·2026
Same author

Safety, feasibility, and technical success of percutaneous cryoablation to treat vascular anomalies of the extremities.

Clinical radiology·2025
Same author

Safety and Feasibility of Endovascular Management of Pediatric Dialysis Access.

Cardiovascular and interventional radiology·2025
Same author

Paediatric sclerotherapy of vascular anomalies of the hand and digits.

Clinical radiology·2025
Same author

Evaluating the effects of hypoxic storage on platelet function and health using a novel storage system.

Transfusion·2024

Area of Science:

  • Neuroscience
  • Pharmacology
  • Perinatal Medicine

Background:

  • Perinatal asphyxia poses significant risks for mortality and cerebral palsy.
  • Hypoxic-ischemic insults during birth can lead to severe neurological sequelae.
  • Novel therapeutic strategies are needed to mitigate the effects of birth asphyxia.

Purpose of the Study:

  • To investigate the neuroprotective potential of flunarizine and MK-801 in models of perinatal asphyxia.
  • To evaluate the efficacy of these agents in preventing neurological damage and seizures post-insult.
  • To explore future therapeutic prospects for managing birth asphyxia complications.

Main Methods:

  • Utilized an infant rat model with unilateral carotid ligation and hypoxia to assess flunarizine's neuroprotection.

Related Experiment Videos

  • Employed a novel fetal sheep model to study the prophylactic effects of flunarizine on cerebral ischemia.
  • Administered MK-801 to evaluate its impact on post-ischemic seizures in relevant animal models.

    • Main Results:

    • Flunarizine demonstrated neuroprotective effects in infant rats subjected to hypoxia.
    • Prophylactic flunarizine treatment significantly altered outcomes in fetal sheep following total cerebral ischemia.
    • MK-801 successfully prevented seizures in the post-ischemic phase.

    Conclusions:

    • Flunarizine holds promise as a neuroprotective agent for conditions like perinatal asphyxia.
    • MK-801 may be beneficial in managing acute seizure complications associated with ischemic brain injury.
    • Further research into these pharmacological interventions is warranted for clinical application.